| Reference |
[1] Cloning and B-cell-epitope mapping of MPT64 from Mycobacterium tuberculosis H37Rv.'Oettinger T., Andersen A.B.Infect. Immun. 62:2058-2064(1994)
[2] High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets.'Harth G., Lee B.Y., Horwitz M.A.Infect. Immun. 65:2321-2328(1997)
[3] Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.'Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E., Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K., Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K., Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K., Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J., Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S., Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S., Barrell B.G.Nature 393:537-544(1998) |
